Figure 3From: Serum nucleosomes during neoadjuvant chemotherapy in patients with cervical cancer. Predictive and prognostic significanceKaplan-Meier estimates of survival at a mean follow-up of 23 months (range, 7–26 months) according to nucleosome values determined in the third chemotherapy course (p = 0.0260). Time to progression-free survival interval was also statistically significant longer in patients who experienced decreased nucleosomes.Back to article page